Christopher W. Krueger, Chief Business Officer at Ventyx Biosciences, Inc. (VTYX), sold 30,000 shares at $34.46 ($1.0M) on 2022-12-13, disclosed to the SEC on 2022-12-15.
Open-market sale of $1.0M VTYX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VTYX | SELL | 2023-10-04 | $869K | — | Filing → |
| VTYX | SELL | 2023-09-07 | $977K | — | Filing → |
| VTYX | SELL | 2023-08-04 | $1.1M | — | Filing → |